The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Balixafortide (a CXCR4 antagonist) plus eribulin in HER2 negative metastatic breast cancer: Dose-response analysis of efficacy from phase I single-arm trial.
 
Peter A. Kaufman
Stock and Other Ownership Interests - Amgen
Honoraria - Lilly
Consulting or Advisory Role - AstraZeneca; Eisai; Lilly; Macrogenics; Merck; Pfizer; Polyphor; Roche/Genentech
Speakers' Bureau - Lilly; Teva
Research Funding - Eisai (Inst); Lilly (Inst); Macrogenics (Inst); Novartis (Inst); Pfizer (Inst); Polyphor (Inst); Roche/Genentech (Inst)
Travel, Accommodations, Expenses - Lilly; Macrogenics; Polyphor
 
Sonia Pernas Simon
Consulting or Advisory Role - Polyphor
Speakers' Bureau - Roche
Travel, Accommodations, Expenses - Roche
 
Miguel Martin
Consulting or Advisory Role - AstraZeneca; Lilly; Novartis; Pfizer; PharmaMar; Roche/Genentech; Taiho Pharmaceutical
Research Funding - Novartis (Inst); Roche (Inst)
 
Marta Gil-Martin
Travel, Accommodations, Expenses - MSD Oncology
 
Patricia Gomez Pardo
No Relationships to Disclose
 
Sara Lopez-Tarruella
No Relationships to Disclose
 
Luis Manso
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Eisai; Lilly; Novartis; Pfizer; Pierre Fabre; Roche/Genentech; Tesaro
Speakers' Bureau - AstraZeneca; Lilly; Novartis; Pfizer; Roche/Genentech
Research Funding - Tesaro
Travel, Accommodations, Expenses - MSD Oncology; Novartis; Roche/Genentech; Tesaro
 
Eva Ciruelos
No Relationships to Disclose
 
Jose Alejandro Perez-Fidalgo
Consulting or Advisory Role - Ability Pharma; Amgen; AstraZeneca; Clovis Oncology; Roche; Tesaro
Speakers' Bureau - AstraZeneca Spain; GlaxoSmithKline; Ipsen; Novartis; Pfizer; PharmaMar; Roche
Patents, Royalties, Other Intellectual Property - Pending patent
Travel, Accommodations, Expenses - AstraZeneca; Pfizer; Roche
 
Cristina Hernando
Consulting or Advisory Role - Novartis
Travel, Accommodations, Expenses - Novartis; Pfizer; Roche
 
Foluso Olabisi Ademuyiwa
Honoraria - Advance Medical; Best Doctors, Inc
Consulting or Advisory Role - Abbvie; AstraZeneca; Cardinal Health; Eisai; Immunomedics; Jounce Therapeutics; Pfizer; QED Therapeutics
Research Funding - Abbvie (Inst); Astellas Pharma (Inst); Immunomedics (Inst); NeoImmuneTech (Inst); Pfizer (Inst); Polyphor (Inst); RNA Diagnostics (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Abbvie; AstraZeneca; Cardinal Health; Eisai; Immunomedics; Jounce Therapeutics; Odonate Therapeutics
 
Katherine N. Weilbaecher
No Relationships to Disclose
 
Ingrid A. Mayer
Consulting or Advisory Role - Abbvie; AstraZeneca; Genentech; GlaxoSmithKline; Immunomedics; Lilly; Macrogenics; Novartis; Pfizer; Puma Biotechnology; Seagen
Research Funding - Genentech (Inst); Novartis (Inst); Pfizer (Inst)
 
Timothy J. Pluard
Consulting or Advisory Role - Genentech; Macrogenics; Pfizer; Seagen
Speakers' Bureau - Genentech/Roche; Novartis; Pfizer; Tempus
Research Funding - Seagen (Inst)
 
Maria Martinez Garcia
Consulting or Advisory Role - Pfizer; Roche
Research Funding - Pfizer
Travel, Accommodations, Expenses - Pfizer; Roche
 
Linda T. Vahdat
Honoraria - Athenex; Osmol Therapeutics; polyphor; R-Pharm; Seagen
Consulting or Advisory Role - Berg Pharma
Speakers' Bureau - Eisai
Research Funding - Immunomedics (Inst); Polyphor (Inst); Seagen (Inst)
Patents, Royalties, Other Intellectual Property - we have a patent pending on the application for BMD progenitor cells (Inst)
 
Francois Philippe Ringeisen
Employment - Polyphor
Stock and Other Ownership Interests - Lilly
 
Alexandra Bobirca
Employment - Polyphor
 
Javier Cortes
Stock and Other Ownership Interests - MedSIR
Honoraria - Celgene; Daiichi Sankyo; Eisai; Lilly; Merck Sharp & Dohme; Novartis; Pfizer; Roche; Samsung
Consulting or Advisory Role - AstraZeneca; Athenex; Bioasis; Biothera; Celgene; Cellestia Biotech; Clovis Oncology; Daiichi Sankyo; ERYTECH Pharma; GlaxoSmithKline; Leuko; Lilly; Merck Sharp & Dohme; Merus; Polyphor; Roche; Seagen; SERVIER
Research Funding - ARIAD (Inst); AstraZeneca (Inst); Baxalta (Inst); Bayer (Inst); Eisai (Inst); Guardant Health (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Piqur (Inst); Puma Biotechnology (Inst); Queen Mary university of London (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Daiichi Sankyo; Eisai; Novartis; Pfizer; Roche